Prevention
It is globally acknowledged that prevention is better than cure and yet most health systems spend less than 1% of their budgets on preventative approaches. A preventative approach can help reduce healthcare costs, improve patient outcomes, and decrease the burden on healthcare systems.
Undervalued and underused: why vaccines are losing ground
10 November 2026
But uptake depends on trust, access and communication, and misinformation can undo much of that value. Grace Hampson is joined by Stephan Lewandowsky, Professor of Cognitive…
Paying for Prevention: Reflections on the 2026 OHE Annual Lecture
30 October 2026
At the 2026 Office of Health Economics (OHE) Annual Lecture, Dr Eduardo Banzon of the Asian Development Bank (ADB) argued that prevention will only attract sustained investment if its case is framed around wider economic returns. He identified six barriers that favour curative care over prevention and proposed three financing routes to overcome them: health taxes, strategic purchasing and blended finance. All three depend on collaboration and co-financing across government, multilateral organisations and industry.
Five unanswered questions from the UK’s Renewed Women’s Health Strategy
16 September 2026
The UK’s Renewed Women’s Health Strategy sets out an ambitious plan. But can the NHS deliver it?
Prevention works, so why don’t we pay for it?
30 June 2026
Grace Hampson is joined by Gundo Weiler, Director of Prevention and Health Promotion at the World Health Organization (WHO) Regional Office for Europe, and Graham Cookson,…
The cost of inaction on LDL cholesterol
24 June 2026
This Insight is based on the WHA79 panel discussion “Lowering Cholesterol, Increasing Impact: The Case for Earlier Action to Address the CV Epidemic”, co-organised by OHE and MSD, at the World Health Assembly in Geneva, May 2026.
Addressing the systemic challenges of underinvestment in prevention
8 June 2026
Prevention of ill-health is an underexploited tool for protecting health systems and societies. It offers the potential to curb increasing demand for healthcare services, increase participation…
The burden of LDL-cholesterol-driven atherosclerotic cardiovascular diseases
31 March 2026
Atherosclerotic cardiovascular disease (ASCVD) is a leading cause of morbidity and mortality globally, and is responsible for substantial health and economic burden to health systems and wider society.
Turning around the NHS: Reflections on the 2025 OHE Annual Lecture
14 October 2025
In this year’s Annual Lecture, Prof Anita Charlesworth takes a closer look at the NHS 10 Year Health Plan, concluding that all is not lost for the NHS, but questions of coherence, capacity, and capability remain.
New OHE model estimates COVID-19 could be associated with costs of £7 billion a year in the UK, without annual autumn vaccinations
13 October 2025
A newly released report commissioned by Moderna modelled a one-year scenario without annual COVID-19 autumn vaccinations.